These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 3546943)

  • 1. Ovarian steroid production in rats treated with gonadotropin-releasing hormone during early pregnancy.
    Sridaran R
    J Steroid Biochem; 1987 Jan; 26(1):1-6. PubMed ID: 3546943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of gonadotropin-releasing hormone treatment on ovarian steroid production during midpregnancy.
    Sridaran R
    Proc Soc Exp Biol Med; 1986 May; 182(1):120-6. PubMed ID: 3515349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory effects of a gonadotropin-releasing hormone agonist on the luteal synthesis of progesterone, estradiol receptors, and prolactin surges during early pregnancy.
    Sridaran R; Ghose M; Mahesh VB
    Endocrinology; 1988 Oct; 123(4):1740-6. PubMed ID: 3046924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of luteal estradiol receptors and progesterone synthesis by a gonadotropin-releasing hormone agonist (WY-40972) during midgestation.
    Sridaran R; Mahesh VB
    Biol Reprod; 1989 Feb; 40(2):276-82. PubMed ID: 2655722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gonadotropin-releasing hormone (GnRH) inhibits ovulation induced with luteinizing hormone (LH) in proestrous hypophysectomized rats.
    de la Lastra M; Leal J
    Life Sci; 1988; 42(4):421-9. PubMed ID: 3276996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraovarian localization of luteinizing hormone/human chorionic gonadotropin stimulation of testosterone and estradiol synthesis in the pregnant rat.
    Sridaran R; Gibori G
    Endocrinology; 1983 May; 112(5):1770-6. PubMed ID: 6832068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Administration of GnRH at estrus influences pregnancy rates, serum concentrations of LH, FSH, estradiol-17 beta, pregnancy-specific protein B, and progesterone, proportion of luteal cell types, and in vitro production of progesterone in dairy cows.
    Mee MO; Stevenson JS; Alexander BM; Sasser RG
    J Anim Sci; 1993 Jan; 71(1):185-98. PubMed ID: 8454542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of short-term treatment of a gonadotropin-releasing hormone agonist on the follicular development and gonadotropin secretion in the rat.
    Krishna A; Srivastava RK; Sridaran R
    Endocr Res; 1996 Aug; 22(3):299-310. PubMed ID: 8875141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct inhibitory effect of gonadotropin-releasing hormone upon luteal luteinizing hormone receptor and steroidogenesis in hypophysectomized rats.
    Jones PB; Hsueh AJ
    Endocrinology; 1980 Dec; 107(6):1930-6. PubMed ID: 6253282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The rapid ovarian secretory response to pituitary stimulation by the gonadotropin-releasing hormone agonist nafarelin in sexual precocity.
    Rosenfield RL; Garibaldi LR; Moll GW; Watson AC; Burstein S
    J Clin Endocrinol Metab; 1986 Dec; 63(6):1386-9. PubMed ID: 2946712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Follicular development, steroidogenesis and gonadotrophin secretion in response to long-term treatment with a gonadotrophin-releasing hormone agonist in the rat.
    Srivastava RK; Krishna A; Sridaran R
    J Endocrinol; 1995 Aug; 146(2):349-57. PubMed ID: 7561648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in rat luteal ultrastructure and P450scc mRNA and protein content after in vivo treatment with a gonadotropin-releasing hormone agonist.
    Smith CJ; Richards JS; Yasin K; Sangster JN; Sridaran R
    Biol Reprod; 1991 Feb; 44(2):382-91. PubMed ID: 2009337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sexual differentiation of galanin gene expression in gonadotropin-releasing hormone neurons.
    Finn PD; McFall TB; Clifton DK; Steiner RA
    Endocrinology; 1996 Nov; 137(11):4767-72. PubMed ID: 8895345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Actions of gonadotropin-releasing hormone analogues in pituitary gonadotrophs and their modulation by ovarian steroids.
    Weiss JM; König SJ; Polack S; Emons G; Schulz KD; Diedrich K; Ortmann O
    J Steroid Biochem Mol Biol; 2006 Oct; 101(2-3):118-26. PubMed ID: 16891115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of gonadotrophin releasing hormone baseline concentrations in the control of pituitary gonadotrophin and ovarian steroid secretion in the pseudopregnant rat.
    Schuiling GA; Valkhof N; Koiter TR
    Hum Reprod; 1996 Jan; 11(1):13-8. PubMed ID: 8671150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feedback effects of estradiol and progesterone on ovulation and fertility of dairy cows after gonadotropin-releasing hormone-induced release of luteinizing hormone.
    Stevenson JS; Pulley SL
    J Dairy Sci; 2016 Apr; 99(4):3003-3015. PubMed ID: 26898279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of mifepristone (RU486) on the pituitary response to gonadotrophin releasing hormone in women.
    Kazem R; Messinis LE; Fowler P; Groome NP; Knight PG; Templeton AA
    Hum Reprod; 1996 Dec; 11(12):2585-90. PubMed ID: 9021355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Even after priming with ovarian steroids or pulsatile gonadotropin-releasing hormone administration, naltrexone is unable to induce ovulation in women with functional hypothalamic amenorrhea.
    Couzinet B; Young J; Brailly S; Chanson P; Schaison G
    J Clin Endocrinol Metab; 1995 Jul; 80(7):2102-7. PubMed ID: 7608262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recovery of hormone secretion after chronic gonadotropin-releasing hormone agonist administration in women with polycystic ovarian disease.
    de Ziegler D; Steingold K; Cedars M; Lu JK; Meldrum DR; Judd HL; Chang RJ
    J Clin Endocrinol Metab; 1989 Jun; 68(6):1111-7. PubMed ID: 2524501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamics of plasma gonadotropin and sex steroid release in polycystic ovarian disease after pituitary-ovarian inhibition with an analog of gonadotropin-releasing hormone.
    Calogero AE; Macchi M; Montanini V; Mongioi A; Maugeri G; Vicari E; Coniglione F; Sipione C; D'Agata R
    J Clin Endocrinol Metab; 1987 May; 64(5):980-5. PubMed ID: 3104389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.